The role of medical affairs (MA) and disease-state education has become essential in advancing patient care and supporting ...

What makes a story powerful? Storytelling is becoming more critical than ever. In medical publications, healthcare providers ...

Merck & Co – known as MSD outside the US and Canada – has entered into an exclusive global licensing agreement worth over ...

Patient pathways promise improved treatments and outcomes, yet they often lead to a maze of access, equity and service issues ...

Researchers led by the Institute of Cancer Research (ICR) have identified a potential new treatment approach to slow down the ...

The European Medicines Group (EMG) has appointed Sanofi’s Rippon Ubhi as its new chair. Ubhi, who will maintain her position ...

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its ...

The explosive growth of Gen AI has caused plenty of consternation as well as celebration, but there’s no turning back the ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

The European Academy of Allergy and Clinical Immunology (EAACI) has launched the first World Anaphylaxis Awareness Day today ...

But as AI has become more prevalent, we have started to recognise the advantages and opportunities it offers through a ...

New Environmental, Social and Governance (ESG) regulations coming into force across the EU in 2025 stand to shift how ...